{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:09:11Z","timestamp":1773281351606,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jfo.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T23:22:50Z","timestamp":1551914570000},"page":"e147-e151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tacrolimus ointment in the management of atopic keratoconjunctivitis"],"prefix":"10.1016","volume":"42","author":[{"given":"D.","family":"Benaim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"T\u00e9tart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bauvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Delcampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Muraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gueudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2019.02.003_bib0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ophtha.2015.07.012","article-title":"Atopic keratoconjunctivitis in children: clinical features and diagnosis","volume":"123","author":"Br\u00e9mond-Gignac","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2019.02.003_bib0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3111\/13696998.2011.576039","article-title":"Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients\u00a0\u2014\u00a0An observational, cross sectional study in four countries in Europe","volume":"14","author":"Virchow","year":"2011","journal-title":"J Med Econ"},{"key":"10.1016\/j.jfo.2019.02.003_bib0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/opep.11.1.17.26437","article-title":"Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire","volume":"11","author":"Pitt","year":"2004","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1055\/s-0034-1368396","article-title":"Atopic keratoconjunctivitis","volume":"231","author":"Sobolewska","year":"2014","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jfo.2019.02.003_bib0140","first-page":"392","article-title":"The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis","volume":"40","author":"Hingorani","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2019.02.003_bib0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2019.02.003_bib0150","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2019.02.003_bib0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ajd.12292","article-title":"Ocular side-effects of topical corticosteroids: what a dermatologist needs to know","volume":"56","author":"Daniel","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0160","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199709183371203","article-title":"A short-term trial of tacrolimus ointment for atopic dermatitis","volume":"337","author":"Ruzicka","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2019.02.003_bib0165","first-page":"CD009864","article-title":"Topical tacrolimus for atopic dermatitis","volume":"7","author":"Cury Martins","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfo.2019.02.003_bib0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2340\/00015555-0803","article-title":"One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: a randomized, double-blind, comparative trial","volume":"90","author":"Mandelin","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0175","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.eye.6702367","article-title":"Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis","volume":"21","author":"Nivenius","year":"2007","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jfo.2019.02.003_bib0180","first-page":"NC05","article-title":"Therapeutic effect of 0.1% tacrolimus eye ointment in allergic ocular diseases","volume":"10","author":"Barot","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jfo.2019.02.003_bib0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ajo.2013.10.006","article-title":"Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis","volume":"157","author":"Al-Amri","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","article-title":"Topical tacrolimus treatment of atopic eyelid disease","volume":"135","author":"Rikkers","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0195","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) NEI-VFQ Field Test Investigators","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0200","series-title":"Surface oculaire\u00a0: rapport SFO 2015","article-title":"Qualit\u00e9 de vie, qualit\u00e9 de vision","author":"Denoyer","year":"2015"},{"key":"10.1016\/j.jfo.2019.02.003_bib0205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0210","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/jdv.12022","article-title":"Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option?","volume":"27","author":"Westland","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ophtha.2016.11.002","article-title":"Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases","volume":"124","author":"Miyazaki","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2019.02.003_bib0220","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/ICO.0b013e3181245172","article-title":"Role of rigid gas-permeable scleral contact lenses in the management of advanced atopic keratoconjunctivitis","volume":"26","author":"Margolis","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2019.02.003_bib0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1468-3083.2008.02933.x","article-title":"Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids","volume":"23","author":"Zribi","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfo.2019.02.003_bib0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jfo.2017.09.005","article-title":"Topical cyclosporine A and risk of ocular surface neoplasia","volume":"41","author":"Rouimi","year":"2018","journal-title":"J Fr Ophtalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551219300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551219300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:09:41Z","timestamp":1759259381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551219300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0181551219300713"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2019.02.003","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus ointment in the management of atopic keratoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}